Canada’s Drug Agency | Drugs, Health Technologies and Systems.
Canada’s Drug Agency | Drugs, Health Technologies and Systems.

Hemin for Injection (Panhematin): Budget Impact Analysis

Details

Files
Project Status:
Completed
Project Line:
Health Technology Review
Project Number:
OB0006-000

This report aims to:

  • Assess, from the Canadian health care system perspective, the budgetary impact of reimbursing hemin for injection (Panhematin) over a three-year period for the amelioration of recurrent and sporadic attacks of acute intermittent porphyria temporally related to the menstrual cycle of susceptible women, after initial carbohydrate therapy is known or suspected to be inadequate.

Files

Hemin for Injection (Panhematin): Budget Impact Analysis Technology Review October 16, 2019 View PDF
Last Updated : October 16, 2019